{"id":"W4405042181","doi":"10.1182/blood-2024-201578","title":"Nemtabrutinib, a Noncovalent Reversible BTK Inhibitor in Relapsed or Refractory Follicular Lymphoma: Results from the Phase 2 Bellwave-003 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Follicular lymphoma; Bruton's tyrosine kinase; Refractory (planetary science); Ibrutinib; Medicine; Cancer research; Lymphoma; Follicular phase; Internal medicine; Chronic lymphocytic leukemia; Oncology; Biology; Leukemia; Tyrosine kinase; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002412997,0.000593833,0.0006608101,0.000191948,0.0002098321,0.0005859048,0.0004580788,0.0005871441,0.003071882],"category_scores_gemma":[0.0007012185,0.0001843698,0.0007672599,0.0002638444,0.0002736789,0.0004970521,0.0002296902,0.001157138,0.0006447721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005932952,"about_ca_system_score_gemma":0.0008502784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006756419,"about_ca_topic_score_gemma":0.002295241,"domain_scores_codex":[0.9996213,0.0001746131,0.00002728832,0.00004596703,0.00007766525,0.00005309337],"domain_scores_gemma":[0.9996419,0.00007961171,0.0001051412,0.00002916993,0.0000453809,0.00009881189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4472869,0.02588239,0.04393951,0.00260435,0.003273141,0.0005140312,0.000386985,0.003659033,0.08920176,0.0005181016,0.02053754,0.3621962],"study_design_scores_gemma":[0.4168753,0.3934561,0.1358841,0.0003129714,0.003823485,0.001435934,0.0001733674,0.002888461,0.01589375,0.0006368014,0.02853524,0.00008447011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766629,0.008956439,0.0008755312,0.0006474506,0.00005620694,0.001720193,0.00440124,0.0001251907,0.006554924],"genre_scores_gemma":[0.9791172,0.004013166,0.001507597,0.001224816,0.00009022492,0.001206191,0.00993116,0.00003550102,0.002874097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003071882,"threshold_uncertainty_score":0.01276124,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03408298947465793,"score_gpt":0.3335598701466478,"score_spread":0.2994768806719899,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}